Midgard Science

Richter BioLogics

Hamburg, Germany richterbiologics.eu From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

Richter BioLogics is a Germany-based CDMO that develops and manufactures biopharmaceuticals derived from bacteria and yeasts. It serves pharmaceutical and biotechnology customers worldwide from locations in Hamburg and Bovenau, with production facilities in Germany and locations also noted in Hungary.

Services

  • Strain development

    Develops strains based on E. coli host systems for peptides, proteins, plasmid DNA products, and vaccines.

    Cell line development

  • Fermentation development

    Provides batch and fed-batch fermentation development, including feasibility studies, scale-up, adaptation, optimization, and reproducibility studies.

    Cell line development

  • Downstream process development

    Develops purification and downstream processes including capture, intermediate purification, polishing, and process optimization.

    Cell line development

  • Process characterization

    Establishes scale-down models and characterizes process parameters for fermentation, chromatography, and TFF.

    Cell line development

  • Analytical development

    Develops product- and process-specific analytical methods, including HCP ELISAs, bioassays, and stability-indicating methods.

  • GMP quality control

    Performs GMP-compliant QC testing, method transfer and validation, in-process and release testing, comparability testing, microbiological testing, and stability testing.

  • Drug substance manufacturing

    Manufactures biological drug substances in cGMP facilities for phase I to III and commercial supply.

    CDMO: development & manufacturing

Capabilities

Assays and studies
  • Process development
  • E. coli expression
  • Antibodies
  • Peptides
  • Analytical development
  • Bioreactors
16 more
  • HPLC
  • Method transfer
  • Method validation
  • Analytical procedure validation
  • Lifecycle management
  • In-process testing
  • Release testing
  • Comparability testing
  • Microbiological testing
  • ICH conform stability testing
  • Raw material testing
  • Cleaning verification
  • Cell bank characterization
  • Bioassay
  • Biosimilarity testing
  • Stability-indicating methods
Scale and capacity
  • 300L production capacity
  • 1500L production capacity
  • Bioreactor capacities of up to 1,500 litres
  • Small scale 0.3L
  • Small scale 1.0L
  • Intermediate scale-up to 10L
  • Two multiproduct GMP facilities
  • Complete lab space of 1325 sqm

Instruments and platforms

  • FPLC
  • HPLC
  • UV/VIS spectrometry
  • AGE
  • PAGE/WB
  • DLS
3 more
  • Nano-DSF
  • Crossflow filtration
  • Tangential flow filtration (TFF)

Modalities and species

Modalities
  • Antibody
  • Peptide
  • Recombinant protein
  • Vaccine
  • Plasmid DNA
Species and models
  • E. coli
  • Pichia
  • Yeasts
  • Bacteria

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: manufacturing and quality system

Details

Type
CRDMO
Founded
1987
Office
offering 300L and 1500L production capacities. As a GMP biologics facilit
Sites
Bovenau, Germany
Serves
Worldwide, Europe, USA, Brazil, South Korea

Public records

FDA drug establishment registration
3006553942 · ANALYSIS source

Similar labs